Miae WOO - Kim & Chang

Bio

Miae Woo is a foreign attorney at Kim & Chang’s corporate practice. Ms. Woo advises corporate and private equity clients in strategic and financial investments. Ms. Woo is also experienced in venture financing and minority investments in high growth companies.

Prior to joining Kim & Chang, Ms. Woo worked at Cooley LLP in Singapore and advised innovative companies and investors in the US and Southeast Asia. Ms. Woo also worked in the New York offices of Weil, Gotshal & Manges LLP and Kirkland & Ellis LLP, with an extensive experience in public and private mergers and acquisitions.

View All

Profile

Experience

Kim & Chang (2021-Present)

Cooley LLP, Singapore (2019-2021)

Weil, Gotshal & Manges LLP, New York (2017-2019)

Kirkland & Ellis LLP, New York (2014-2017)

Representative Mattersshow

Advised a consortium of Korean equity investors in its investment in a US advanced nuclear technology company.
Advised a Korean E&C company in its SPAC PIPE investment and investment in a small-modular nuclear technology company.
Advised a Korean E&C company in its investment in a US micro-modular nuclear technology company.
Advised a Korean chemical company in its pending acquisition of a Korean chemical company.
Advised a global private equity fund in its acquisitions of controlling stakes in Korean food companies.
Advised a global private equity fund in its sale of shares in a Korean eyewear company.
Advised a French cosmetics company in connection with the JV formation with a Korean hotel company and a private equity fund.
Advised a Singaporean sovereign wealth fund in its sale of shares in a Korean credit card company to a Taiwan-based insurance company and a Taiwan-based bank.
Advised a Korean ICT company in its investment in a Singapore-based ICT Company.
Advised a Korean private equity fund in connection with its follow-on investment in a Singapore-e-commerce company.
Advised a Chinese fund in its investment in a Korean biotech company.
Advised a Korean company in its Series B-3 investment in a US digital asset brokerage platform.
Advised a Korean biotech company in its RCPS financing.

Representative Activitiesshow

Publications/Activities

“The Legal and Practical Issues related to Simple Agreement for Future Equity (“SAFE”),” BFL Vol.121 (Co-author, Center for Financial Law, 2023)
Chambers Global Practice Guides - Shareholders’ Rights & Shareholder Activism 2022: Korea Chapter (Co-author, Chambers and Partners, 2022)